Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis

Thrombosis Research

Volumn 125, Issue 4, 2010, Pages 367-369

  Perés Wingeyer, Silvia ^a   de Larrañaga, Gabriela ^a   Cunto, Eleonora ^a   Fontana, Laura ^a   Nogueras, Cristina ^a   San Juan, Jorge ^a  

^a HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

DNA POLYMORPHISM; FIBRINOLYSIS; GENE OVEREXPRESSION; HUMAN; LETTER; LEUKOCYTE MIGRATION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROMOTER REGION; SEPSIS;

HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC;

EID: 77949567949     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.04.006     Document Type: Letter

References (17)

1. Winning J., Claus R.A., Huse K., and Bauer M. Molecular biology on the ICU. Minerva Anestesiol 72 (2006) 255-267
2. Dombrovskiy V.Y., Martin A.A., Sunderram J., and Paz H.L. Rapid increase in hospitalization and mortality rates for severe sepsis in the United State: A trend analysis from 1993 to 2003. Crit Care Med 35 (2007) 1244-1250
3. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101 (2003) 3765-3777
4. Zeerleder S., Schroeder V., Hack C.E., Kohler H.P., and Wuillemin W.A. TAFI and PAI-1 levels in human sepsis. Thromb Res 118 (2006) 205-212
5. Kornelise R.F., Hazelzet J.A., Savelkoul H.F.J., Hop W.C., Suur M.H., Borsboom A.N., et al. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. JID 173 (1996) 1148-1156
6. Renckens R., Roelofs J.J., Bonta P.I., Florquin S., de Vries C.J., Levi M., et al. Plasminogen activator inhibitor type-1 is protective during severe Gram-negative pneumonia. Blood 109 (2007) 1593-1601
7. Holmes C.L., Russell J.A., and Walley K.R. Genetic polymorphism in sepsis and septic shock. Chest 124 (2003) 1103-1115
8. Tang B.M.P., McLean A.S., Dawes I.W., Huang S.J., Cowley M.J., and Lin R.C.Y. Gene-expression profiling of Gram-positive and Gram-negative sepsis in critically ill patients. Crit Care Med 36 (2008) 1125-1128
9. Emonts M., Hazelzet J.A., de Groot R., and Hermans P.W. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 3 (2003) 565-577
10. Texereau J., Pene F., Chiche J.D., Rousseau C., and Mira J.P. Importance of hemostatic gene polymorphism for susceptibility to and outcome of severe sepsis. Crit Care Med 32 (2004) s313-9
11. Geishofer G., Binder A., Müller M., Zöhrer B., Resch B., Müller W., et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur J Pediatr 164 (2005) 486-490
12. Jessen M.C., Lindboe S.B., Petersen A.L., Eugen-Olsen J., and Benfield. Common TNF-α, IL-1β, PAI-1, uPA, CD 14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect Dis 7 (2007) 108
13. Moreno R.P., Metnitz B., Adler L., Hoechtl A., Bauer P., Metnitz P.G.H., and SAPS 3 Investigators. Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Med 34 (2008) 496-504
14. Orr N., Bekker V., and Chanock S. Genetic association studies: marking them well. JID 194 (2006) 1475-1477
15. Cooper D.N., Nussbaum R.L., and Krawczak M. Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet 110 (2002) 207-208
16. El-Serag H.B., White D.L., and Mitra N. Genetic association studies: from "searching under the lamppost" to "fishing in the pond". Gastroenterology 134 (2008) 62-64
17. Arts D.G., Keizer N.F., Vroom M.B., and de Jonge E. Reliability and accuracy of Sequential Organ Failure Assessment (SOFA) scoring. Crit Care Med 33 (2005) 1988-1993